DUSP2 and head and neck squamous cell carcinoma: Similarly, the methylation of dual-specificity phosphatase-2 (DUSP2) has been investigated in an attempt to predict the response of patients with locally advanced HNSCC (LA-HNSCC) to chemoradiotherapy (CRT) treatment regimens [82].